CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis: San Carlos, California Saturday, January 11, 20 ...

Newron Pharma, Myung In Pharm ink license agreement to develop, manufacture & commercialize Newron’s evenamide in South Korea: Milan Saturday, January 11, 2025, 16:00 Hrs [IST] ...

The Union ministry of commerce & industry has issued a notification introducing amendments to the Foreign Trade Policy (FTP) 2023, aimed at fostering enhanced stakeholder engagement. The notification, ...

The Karnataka Pharma Retailers & Distributors Organization (KPRDO) has urged the Union health ministry for reimbursement for cut strips of expiry dated medicines. In a communication to the Ministry ...

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is ...

Indian pharmaceutical companies are operating in a highly regulated environment, with rules and compliance standards often being prescriptive. While these regulations are essential to ensure quality, ...

Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that it has acquired Galzin (zinc acetate). “This ...

GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...

Artificial intelligence (AI) and machine learning (ML) are poised to redefine the landscape of critical care medicine, offering innovative solutions to the challenges faced in intensive care units ...

FORE Biotherapeutics highlights pipeline achievements for its oncology programme; Provides objectives for 2025: Philadelphia Saturday, January 11, 2025, 17:00 Hrs [IST] FORE Bioth ...

Expressing its concern over the Department of Expenditure's (DoE) decision to turn down the Department of Pharmaceuticals (DoP)’s proposal for setting up separate National Institutes for Medical ...

The Federal Court of Australia brought an end to the last Roundup case in Australia, closing all pending injury litigation there. The Court granted the plaintiffs’ request to discontinue the Fenton ...